Regulus Therapeutics Stock Return On Asset
| RGLSDelisted Stock | USD 8.16 0.01 0.12% |
Fundamental analysis of Regulus Therapeutics allows traders to better anticipate movements in Regulus Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Regulus |
Regulus Therapeutics Company Return On Asset Analysis
Regulus Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Regulus Therapeutics Return On Asset | -0.34 |
Most of Regulus Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Regulus Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Regulus Therapeutics has a Return On Asset of -0.3423. This is 96.09% lower than that of the Biotechnology sector and 98.55% lower than that of the Health Care industry. The return on asset for all United States stocks is 144.5% higher than that of the company.
Regulus Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Regulus Therapeutics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Regulus Therapeutics could also be used in its relative valuation, which is a method of valuing Regulus Therapeutics by comparing valuation metrics of similar companies.Regulus Therapeutics is currently under evaluation in return on asset category among its peers.
Regulus Fundamentals
| Return On Equity | -0.54 | |||
| Return On Asset | -0.34 | |||
| Current Valuation | 500.99 M | |||
| Shares Outstanding | 69.23 M | |||
| Shares Owned By Insiders | 2.70 % | |||
| Shares Owned By Institutions | 82.87 % | |||
| Number Of Shares Shorted | 2.09 M | |||
| Price To Earning | (0.69) X | |||
| Price To Book | 8.19 X | |||
| Price To Sales | 7.43 X | |||
| Gross Profit | (36.15 M) | |||
| EBITDA | (45.85 M) | |||
| Net Income | (46.36 M) | |||
| Cash And Equivalents | 47.53 M | |||
| Cash Per Share | 3.25 X | |||
| Total Debt | 274 K | |||
| Debt To Equity | 0.17 % | |||
| Current Ratio | 8.82 X | |||
| Book Value Per Share | 1.04 X | |||
| Cash Flow From Operations | (41.67 M) | |||
| Short Ratio | 1.57 X | |||
| Earnings Per Share | (0.68) X | |||
| Price To Earnings To Growth | (0.04) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 34 | |||
| Beta | 0.37 | |||
| Market Capitalization | 564.95 M | |||
| Total Asset | 84.18 M | |||
| Retained Earnings | (559.57 M) | |||
| Working Capital | 74.85 M | |||
| Current Asset | 134.26 M | |||
| Current Liabilities | 12.63 M | |||
| Net Asset | 84.18 M |
About Regulus Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Regulus Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Regulus Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Regulus Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Regulus Stock
If you are still planning to invest in Regulus Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regulus Therapeutics' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |